Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Change in Inventory (2016 - 2025)

Ocular Therapeutix (OCUL) has 12 years of Change in Inventory data on record, last reported at $76000.0 in Q4 2025.

  • For Q4 2025, Change in Inventory fell 88.03% year-over-year to $76000.0; the TTM value through Dec 2025 reached $524000.0, down 28.71%, while the annual FY2025 figure was $524000.0, 28.71% down from the prior year.
  • Change in Inventory reached $76000.0 in Q4 2025 per OCUL's latest filing, down from $449000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $635000.0 in Q4 2024 and bottomed at -$230000.0 in Q2 2025.
  • Average Change in Inventory over 5 years is $118150.0, with a median of $64500.0 recorded in 2023.
  • Peak YoY movement for Change in Inventory: soared 1432.14% in 2022, then crashed 751.85% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $28000.0 in 2021, then skyrocketed by 1432.14% to $429000.0 in 2022, then crashed by 88.81% to $48000.0 in 2023, then skyrocketed by 1222.92% to $635000.0 in 2024, then crashed by 88.03% to $76000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were $76000.0 in Q4 2025, $449000.0 in Q3 2025, and -$230000.0 in Q2 2025.